Document Detail


Filtration for free drug level monitoring: carbamazepine and valproic acid.
MedLine Citation:
PMID:  6424279     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Free carbamazepine and valproic acid monitoring using the EMIT FreeLevel filtration system was evaluated and compared with reference equilibrium dialysis and gas chromatographic (GC) techniques. For carbamazepine, free levels after filtration or dialysis were essentially identical (mean 1.74 vs. 1.77 mg/L, r = 0.940, n = 28, EMIT assay). Free levels were 16% higher by EMIT than by GC, possibly due to cross-reaction with carbamazepine-10,11-epoxide. Free fractions were not significantly different using any combination of filtration or dialysis with EMIT or GC (means 0.24-0.26). There was a significant correlation between epoxide and parent-drug free fractions (r = 0.642). Free fraction varied from 0.20 to 0.41 among 61 patient samples and was independent of total drug concentration. For valproic acid, there was a strong correlation between filtration and dialysis results for free level (r = 0.974) and free fraction (r = 0.892), but filtration values were 6-7% higher. Free fraction was concentration dependent (r = 0.597), and lower free fractions by dialysis were attributed to dilution of total drug concentration. Free fraction varied from 0.01 to 0.14 among 50 patient samples. For carbamazepine and valproic acid the EMIT FreeLevel filtration system compared favorably with equilibrium dialysis, and had the advantage of being rapid.
Authors:
R H Levy; P N Friel; I Johno; L M Linthicum; L Colin; K Koch; V A Raisys; A J Wilensky; N R Temkin
Related Documents :
2260339 - Excipients in valproic acid syrup may cause diarrhea: a case report.
8801059 - Conjugation of glutathione with a toxic metabolite of valproic acid, (e)-2-propyl-2,4-p...
19104179 - Cu-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagul...
21561879 - Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk...
15316109 - Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
22054129 - Expanding the catalytic repertoire of dnazymes by modified nucleosides.
16190619 - Isolation and antifungal activity of 4-phenyl-3-butenoic acid from streptomyces koyange...
21967029 - Vasodilator effect of phlomis bracteosa constituents is mediated through dual endotheli...
18472939 - Effects of ursolic acid and its analogues on soybean 15-lipoxygenase activity and the p...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Therapeutic drug monitoring     Volume:  6     ISSN:  0163-4356     ISO Abbreviation:  Ther Drug Monit     Publication Date:  1984  
Date Detail:
Created Date:  1984-05-14     Completed Date:  1984-05-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7909660     Medline TA:  Ther Drug Monit     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  67-76     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Proteins / metabolism
Carbamazepine / analogs & derivatives,  blood*
Chromatography, Gas
Dialysis
Filtration / methods
Humans
Protein Binding
Valproic Acid / blood*
Grant Support
ID/Acronym/Agency:
N01-NS-6-2341/NS/NINDS NIH HHS; NS 17111/NS/NINDS NIH HHS; RR-37/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Blood Proteins; 298-46-4/Carbamazepine; 36507-30-9/carbamazepine epoxide; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The place of saliva in antiepileptic drug monitoring.
Next Document:  General considerations concerning viscous materials in ophthalmic surgery.